Patrick Lang receives NRSA F30 April 1, 2015 By Janice Warfford Patrick Lang receives NRSA F30 through the National Cancer Institute entitled “ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development”. Filed Under: Categories: News More from Department of Cell Biology and Physiology Jessica Cote Awarded Postdoctoral Fellowship CBP Helps Sponsor Triangle Brain Bee Max Hockenberry featured in Vital Signs Series